10/31/14 AMED 26.10 Amedisys Inc $AMED Hit a 52 week high of 26.34 Closing the day 10/31/14 at 26.10 +0.82 +3.24% With a day low of 25.33 and a total volume of 784,700.
AMED Recent Posts: http://investorshangout.com/Amedisys-Inc-AMED-53302/
AMED Amedisys Inc Recent Headline News
Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 10.50 (+0.02), EMR: 64.06 (+0.64), AMED: 26.10 (+0.82), AAPL: 108.00 (+1.02)
Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.84 (+0.02), ACMP: 62.29 (-0.64), AMAG: 33.01 (-0.95), AMED: 26.10 (+0.82), ACCO: 8.23 (+0.33)
Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 26.10 (+0.82)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.99 (+1.39), ABMD: 32.79 (+1.44), BGFV: 12.31 (+0.29), RDCM: 8.60 (+0.10), AMED: 26.10 (+0.82), MRCY: 13.98 (-0.07), OMER: 16.57 (unch), ESBF: 18.66 (+0.07), EVOK: 6.70 (+0.76), IQNT: 16.83 (+1.10), KONA: 22.53 (+0.57), TQNT: 21.63 (+1.56), LAKE: 14.10 (-0.14), SAJA: 6.48 (-0.34)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 47.55 (-0.04), ZLTQ: 25.64 (-1.01), EA: 40.97 (+1.12), AMED: 26.10 (+0.82)
Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 25.81 (+0.14), SCTY: 59.18 (+2.85), JCP: 7.61 (-0.02), AMED: 26.10 (+0.82), RFMD: 13.01 (+0.94)
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)
Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 26.10 (+0.82)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 26.10 (+0.82)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 26.10 (+0.82)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 26.10 (+0.82)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.46 (+0.26), RYAM: 28.53 (+0.67), CLF: 11.23 (+0.73), AMED: 26.10 (+0.82), LOCK: 16.91 (+0.01)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.46 (-0.02), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 26.10 (+0.82)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 26.10 (+0.82)
Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 26.10 (+0.82)
Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.75 (+0.51), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 43.15 (+0.18), AFAM: 29.44 (+0.69), AMED: 26.10 (+0.82), GTIV: 19.70 (+0.06)
AMED Recent Posts: http://investorshangout.com/Amedisys-Inc-AMED-53302/
AMED Amedisys Inc Recent Headline News
Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 10.50 (+0.02), EMR: 64.06 (+0.64), AMED: 26.10 (+0.82), AAPL: 108.00 (+1.02)
Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.84 (+0.02), ACMP: 62.29 (-0.64), AMAG: 33.01 (-0.95), AMED: 26.10 (+0.82), ACCO: 8.23 (+0.33)
Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 26.10 (+0.82)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.99 (+1.39), ABMD: 32.79 (+1.44), BGFV: 12.31 (+0.29), RDCM: 8.60 (+0.10), AMED: 26.10 (+0.82), MRCY: 13.98 (-0.07), OMER: 16.57 (unch), ESBF: 18.66 (+0.07), EVOK: 6.70 (+0.76), IQNT: 16.83 (+1.10), KONA: 22.53 (+0.57), TQNT: 21.63 (+1.56), LAKE: 14.10 (-0.14), SAJA: 6.48 (-0.34)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 47.55 (-0.04), ZLTQ: 25.64 (-1.01), EA: 40.97 (+1.12), AMED: 26.10 (+0.82)
Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 25.81 (+0.14), SCTY: 59.18 (+2.85), JCP: 7.61 (-0.02), AMED: 26.10 (+0.82), RFMD: 13.01 (+0.94)
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 54.01 (+0.96), USPH: 43.15 (+0.18), RDNT: 9.30 (+0.10), AMED: 26.10 (+0.82)
Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 26.10 (+0.82)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 26.10 (+0.82)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 26.10 (+0.82)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 26.10 (+0.82)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.46 (+0.26), RYAM: 28.53 (+0.67), CLF: 11.23 (+0.73), AMED: 26.10 (+0.82), LOCK: 16.91 (+0.01)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.46 (-0.02), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 26.10 (+0.82)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 26.10 (+0.82)
Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 26.10 (+0.82)
Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.75 (+0.51), AMED: 26.10 (+0.82), HLS: 40.33 (+0.72), GTIV: 19.70 (+0.06)
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 43.15 (+0.18), AFAM: 29.44 (+0.69), AMED: 26.10 (+0.82), GTIV: 19.70 (+0.06)
